Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL639800 | 1.00 | ALDH1A1 (0.32) | ALDH1A1MMP3BCL2L1 | |
| SCHEMBL639798 | 1.00 | ALDH1A1 (0.32) | ALDH1A1MMP3BCL2L1 | |
| SCHEMBL9788612 | 0.82 | ESR1 (0.39) | ALDH1A1MMP3BCL2L1 | |
| SCHEMBL2931007 | 0.80 | CYP1A2 (0.32) | — | |
| SCHEMBL6744628 | 0.72 | KDM4E (0.43) | ALDH1A1 | |
| SCHEMBL16807414 | 0.68 | ADAMTS4 (0.37) | ALDH1A1 | |
| SCHEMBL28153377 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL11237308 | 0.65 | BACE1 (0.32) | ALDH1A1 | |
| SCHEMBL30139970 | 0.65 | CYP3A4 (0.33) | ALDH1A1 | |
| SCHEMBL20860346 | 0.64 | MAOB (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2825624-B2 | WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-2825624-B1 | WATER SOLUBLE COMPOSITIONS INCORPORATING ENZYMES, AND METHOD OF MAKING SAME | MONOSOL LLC (US) | 2018-04-25 | — | — | EP | disclosed |
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | BP CORP NORTH AMERICA INC (US) | 2015-08-27 | — | — | US | disclosed |
| US-8962800-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2015-02-24 | — | — | US | disclosed |
| EP-2616481-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | Aligna Technologies, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20130143304-A9 | LIGF-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2013-06-06 | — | — | US | disclosed |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120202257-A1 | LIGE-TYPE ENZYMES FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20120202272-A1 | LIGE-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC | 2012-08-09 | — | — | US | disclosed |
| US-20120202258-A1 | LIGE-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20070213541-A1 | Synthesis of acetonides from aryl silanes | DOW CORNING CORPORATION | 2007-09-13 | — | — | US | disclosed |
| US-7179932-B2 | Synthesis of cis-diols from aryl silanes | GENENCOR INTERNATIONAL, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| EP-1711618-A1 | METHODS FOR DETECTING MARKERS ASSOCIATED WITH ENDOMETRIAL DISEASE OR PHASE | MOUNT SINAI HOSPITAL CORPORATION (CA) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005061725-A1 | METHODS FOR DETECTING MARKERS ASSOCIATED WITH ENDOMETRIAL DISEASE OR PHASE | MOUNT SINAI HOSPITAL (CA) | 2005-07-07 | — | — | WO | disclosed |
| US-20050118665-A1 | Methods for conducting assays for enzyme activity on protein microarrays | PROTOMETRIX, INC. | 2005-06-02 | — | — | US | disclosed |
| US-6794167-B2 | PROTEIN COMPLEX FOR USE IN THE BIOSYNTHESIS OF PREFERENTIAL COMPOUNDS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2004-09-21 | — | — | US | disclosed |
| US-20030022335-A1 | Novel polypeptides and methods for their use | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2003-01-30 | — | — | US | disclosed |
| US-5036009-A | Biochemical process | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-07-30 | — | — | US | disclosed |
| US-4508822-A | Biochemical process | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1985-04-02 | — | — | US | disclosed |
| EP-0076606-A1 | Biochemical process | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | POLN, POLM, POLI | ALDH1A1 2292/4885MMP3 1007/4885BCL2L1 2687/4885 |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | ALDH1A1 2292/4885MMP3 1007/4885BCL2L1 2687/4885 |
| US-20070213541-A1 | Synthesis of acetonides from aryl silanes | CYP21A2, CYP11B1, CYP11B2 | ALDH1A1 191/4885MMP3 2815/4885BCL2L1 3808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.